| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |